147 related articles for article (PubMed ID: 18501072)
1. Evaluation of quality of life in patients with metastatic colorectal cancer treated with capecitabine.
Segalla JG; Van Eyll B; Federico MH; Skare NG; Franke FA; Perdicaris MR; Filho Ude P; Gampel O; Cabral S; Ribeiro Rde A
Clin Colorectal Cancer; 2008 Mar; 7(2):126-33. PubMed ID: 18501072
[TBL] [Abstract][Full Text] [Related]
2. Health-related quality of life and cost comparison of adjuvant capecitabine versus 5-fluorouracil/leucovorin in stage III colorectal cancer patients.
Chen HH; Chen WT; Lee HC; Lin JK; Fang CY; Chou YH; Lin PC; Lin BW; Huang CC; Yeh CH; Hsu HH; Chen HC; Ting WC; Yang MC; Tan EC
Qual Life Res; 2015 Feb; 24(2):473-84. PubMed ID: 25099199
[TBL] [Abstract][Full Text] [Related]
3. Comparing the effectiveness of capecitabine versus 5-fluorouracil/leucovorin therapy for elderly Taiwanese stage III colorectal cancer patients based on quality-of-life measures (QLQ-C30 and QLQ-CR38) and a new cost assessment tool.
Lin JK; Tan EC; Yang MC
Health Qual Life Outcomes; 2015 May; 13():61. PubMed ID: 25986478
[TBL] [Abstract][Full Text] [Related]
4. Quality of life in non-early rectal cancer treated by neoadjuvant radio-chemotherapy and endoluminal loco-regional resection (ELRR) by transanal endoscopic microsurgery (TEM) versus laparoscopic total mesorectal excision.
D'Ambrosio G; Paganini AM; Balla A; Quaresima S; Ursi P; Bruzzone P; Picchetto A; Mattei FI; Lezoche E
Surg Endosc; 2016 Feb; 30(2):504-511. PubMed ID: 26045097
[TBL] [Abstract][Full Text] [Related]
5. Quality-of-life impairment after endoluminal locoregional resection and laparoscopic total mesorectal excision.
Lezoche E; Paganini AM; Fabiani B; Balla A; Vestri A; Pescatori L; Scoglio D; D'Ambrosio G; Lezoche G
Surg Endosc; 2014 Jan; 28(1):227-34. PubMed ID: 24002918
[TBL] [Abstract][Full Text] [Related]
6. Physical function and quality of life in frail and/or elderly patients with metastatic colorectal cancer treated with capecitabine and bevacizumab: an exploratory analysis.
Ward P; Hecht JR; Wang HJ; Dichmann R; Liem AK; Chan D; Patel R; Hu EH; Tchekmedyian NS; Wainberg ZA; Naeim A
J Geriatr Oncol; 2014 Oct; 5(4):368-75. PubMed ID: 25002322
[TBL] [Abstract][Full Text] [Related]
7. Quality of life in non-metastasic colorectal cancer patients in FOLFOX or XELOX therapy.
Sánchez-Gundín J; Fernández-Carballido AM; Torres-Suárez AI; Barreda-Hernández D
Farm Hosp; 2019 Mar; 43(2):56-60. PubMed ID: 30848178
[TBL] [Abstract][Full Text] [Related]
8. Randomised study of tegafur-uracil plus leucovorin versus capecitabine as first-line therapy in elderly patients with advanced colorectal cancer--TLC study.
Kroep JR; van Werkhoven E; Polee M; van Groeningen CJ; Beeker A; Erdkamp F; Weijl N; van Bochove A; Erjavec Z; Kapiteijn E; Stiggelbout AM; Nortier HW; Gelderblom H
J Geriatr Oncol; 2015 Jul; 6(4):307-15. PubMed ID: 26073532
[TBL] [Abstract][Full Text] [Related]
9. Validation of the Danish version of the disease specific instrument EORTC QLQ-CR38 to assess health-related quality of life in patients with colorectal cancer.
Thaysen HV; Jess P; Laurberg S; Groenvold M
Health Qual Life Outcomes; 2012 Dec; 10():150. PubMed ID: 23241096
[TBL] [Abstract][Full Text] [Related]
10. The construction and testing of the EORTC colorectal cancer-specific quality of life questionnaire module (QLQ-CR38). European Organization for Research and Treatment of Cancer Study Group on Quality of Life.
Sprangers MA; te Velde A; Aaronson NK
Eur J Cancer; 1999 Feb; 35(2):238-47. PubMed ID: 10448266
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the FACT-C, EORTC QLQ-CR38, and QLQ-CR29 quality of life questionnaires for patients with colorectal cancer: a literature review.
Ganesh V; Agarwal A; Popovic M; Cella D; McDonald R; Vuong S; Lam H; Rowbottom L; Chan S; Barakat T; DeAngelis C; Borean M; Chow E; Bottomley A
Support Care Cancer; 2016 Aug; 24(8):3661-8. PubMed ID: 27193118
[TBL] [Abstract][Full Text] [Related]
12. Health-related quality of life in patients with advanced colorectal cancer: results from a phase II study of S-1 combined with irinotecan (CPT-11).
Tsunoda A; Yasuda N; Nakao K; Narita K; Watanabe M; Matsui N; Tsunoda Y; Kusano M
Int J Clin Oncol; 2010 Jun; 15(3):280-6. PubMed ID: 20232103
[TBL] [Abstract][Full Text] [Related]
13. Study on adherence to capecitabine among patients with colorectal cancer and metastatic breast cancer.
Figueiredo Junior AG; Forones NM
Arq Gastroenterol; 2014; 51(3):186-91. PubMed ID: 25296077
[TBL] [Abstract][Full Text] [Related]
14. Quality of life in a randomized trial comparing two neoadjuvant regimens for locally advanced rectal cancer-INCAGI004.
Araujo RO; Vieira FM; Victorino AP; Torres C; Martins I; Guaraldi S; Valadão M; Linhares E; Ferreira CG; Thuler LC
Support Care Cancer; 2022 Aug; 30(8):6557-6572. PubMed ID: 35486228
[TBL] [Abstract][Full Text] [Related]
15. The role of personality in the course of health-related quality of life and disease-specific health status among colorectal cancer survivors: A prospective population-based study from the PROFILES registry.
Husson O; Vissers PA; Denollet J; Mols F
Acta Oncol; 2015 May; 54(5):669-77. PubMed ID: 25752968
[TBL] [Abstract][Full Text] [Related]
16. Phase II clinical trial of preoperative combined chemoradiation for T3 and T4 resectable rectal cancer: preliminary results.
Tjandra JJ; Reading DM; McLachlan SA; Gunn IF; Green MD; McLaughlin SJ; Millar JL; Pedersen JS
Dis Colon Rectum; 2001 Aug; 44(8):1113-22. PubMed ID: 11535850
[TBL] [Abstract][Full Text] [Related]
17. Preoperative chemoradiation for locally advanced rectal cancer with capecitabine 2,000 mg/m2/day.
Veerasarn V; Boonnuch W; Chinswangwatanakul V; Lohsiriwat D; Mahamadsolaeh P
J Med Assoc Thai; 2008 Oct; 91(10):1583-8. PubMed ID: 18972903
[TBL] [Abstract][Full Text] [Related]
18. Cost analysis of capecitabine vs 5-fluorouracil-based treatment for metastatic colorectal cancer patients.
De Portu S; Mantovani LG; Ravaioli A; Tamburini E; Bollina R; Cozzi C; Grimaldi AM; Testa TE; Bianchessi C; Carteni G
J Chemother; 2010 Apr; 22(2):125-8. PubMed ID: 20435573
[TBL] [Abstract][Full Text] [Related]
19. Health utility scores of colorectal cancer based on societal preference in Japan.
Shiroiwa T; Fukuda T; Tsutani K
Qual Life Res; 2009 Oct; 18(8):1095-103. PubMed ID: 19626462
[TBL] [Abstract][Full Text] [Related]
20. Oral capecitabine compared with intravenous fluorouracil plus leucovorin in patients with metastatic colorectal cancer: results of a large phase III study.
Van Cutsem E; Twelves C; Cassidy J; Allman D; Bajetta E; Boyer M; Bugat R; Findlay M; Frings S; Jahn M; McKendrick J; Osterwalder B; Perez-Manga G; Rosso R; Rougier P; Schmiegel WH; Seitz JF; Thompson P; Vieitez JM; Weitzel C; Harper P;
J Clin Oncol; 2001 Nov; 19(21):4097-106. PubMed ID: 11689577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
